566 related articles for article (PubMed ID: 17982080)
1. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.
Giddings OK; Eickhoff CS; Sullivan NL; Hoft DF
Infect Immun; 2010 Mar; 78(3):1333-8. PubMed ID: 20048046
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
[TBL] [Abstract][Full Text] [Related]
4. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
6. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
[TBL] [Abstract][Full Text] [Related]
8. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
Garg N; Tarleton RL
Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.
Pereira-Chioccola VL; Costa F; Ribeirão M; Soares IS; Arena F; Schenkman S; Rodrigues MM
Parasite Immunol; 1999 Feb; 21(2):103-10. PubMed ID: 10101720
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
[TBL] [Abstract][Full Text] [Related]
11. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
[TBL] [Abstract][Full Text] [Related]
12. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.
Araújo AF; de Alencar BC; Vasconcelos JR; Hiyane MI; Marinho CR; Penido ML; Boscardin SB; Hoft DF; Gazzinelli RT; Rodrigues MM
Infect Immun; 2005 Sep; 73(9):6017-25. PubMed ID: 16113322
[TBL] [Abstract][Full Text] [Related]
13. Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells.
de Alencar BC; Araújo AF; Penido ML; Gazzinelli RT; Rodrigues MM
Vaccine; 2007 Aug; 25(32):6018-27. PubMed ID: 17629597
[TBL] [Abstract][Full Text] [Related]
14. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
Wizel B; Nunes M; Tarleton RL
J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.
Eickhoff CS; Vasconcelos JR; Sullivan NL; Blazevic A; Bruna-Romero O; Rodrigues MM; Hoft DF
PLoS Negl Trop Dis; 2011 Mar; 5(3):e983. PubMed ID: 21408124
[TBL] [Abstract][Full Text] [Related]
16. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
Bontempi I; Fleitas P; Poato A; Vicco M; Rodeles L; Prochetto E; Cabrera G; Beluzzo B; Arias D; Racca A; Guerrero S; Marcipar I
Immunotherapy; 2017 Jun; 9(7):555-565. PubMed ID: 28595515
[TBL] [Abstract][Full Text] [Related]
17. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
[TBL] [Abstract][Full Text] [Related]
18. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.
Costa F; Franchin G; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM
Vaccine; 1998 May; 16(8):768-74. PubMed ID: 9627933
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
[TBL] [Abstract][Full Text] [Related]
20. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
